Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity.

@article{Jo2015TargetingFP,
  title={Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity.},
  author={Jae-Cheol Jo and Eun Kyoung Choi and Jae-Sik Shin and J H Moon and S W Hong and Ha-reum Lee and Seung-mi Kim and S A Jung and Dae-Hee Lee and Seang Hwan Jung and Sun-Hye Lee and Jeong Eun Kim and Kyu-pyo Kim and Yong Sang Hong and Y Suh and Se Jin Jang and Eun Kyung Choi and Jung Shin Lee and D H Jin and Tae Won Kim},
  journal={Molecular cancer therapeutics},
  year={2015},
  volume={14 11},
  pages={2613-22}
}
The MET receptor tyrosine kinase, the receptor for hepatocyte growth factor (HGF), has been implicated in cancer growth, invasion, migration, angiogenesis, and metastasis in a broad variety of human cancers, including human hepatocellular carcinoma (HCC). Recently, MET was suggested to be a potential target for the personalized treatment of HCC with an… CONTINUE READING